It was cancelled due to illness. Looks like GALE is taking a punch in the gut. Think that illness made GALE shares ill today. Big miss because I believe some thought that GALE would announce the 700th patient being dosed in the Phase III PRESENT trial at that conference. Disappointment = Price drop.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.